Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Site Randomized, Clinical Trial Comparing the Concomitant Use of MicroMatrix® With Cytal™ Wound Matrix 2-Layer to Standard of Care in Patients With Stage 3 or 4 Pressure Injuries

NCT03283787 is registered in ClinicalTrials.gov with Integra LifeSciences Corporation as lead sponsor.

NCT NCT03283787
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03283787 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Site Randomized, Clinical Trial Comparing the Concomitant Use of MicroMatrix® With Cytal™ Wound Matrix 2-Layer to Standard of Care in Patients With Stage 3 or 4 Pressure Injuries
Lead sponsor
Integra LifeSciences Corporation
Phase
Not applicable
Overall status
Completed
Start date
April 1, 2017
Completion date
December 23, 2019
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pressure ulcer, pressure ulcer, stage iv, pressure ulcers stage iii